Raritan Pharmaceuticals, Inc.

Form 483

East Brunswick, New Jersey, United StatesFEI 3004083931Issued October 20, 2016

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 3004083931.

Observations11

Issue DateOctober 20, 2016

StatusNo Warning Letter

Related Inspections8

Establishment Details

Firm: Raritan Pharmaceuticals, Inc.
Location: East Brunswick, New Jersey, United States
FEI Number: 3004083931
Product Type: Drugs
Issue Date: October 20, 2016
Country: United States

Inspection History, 2009 to 2025

NAI2

VAI4

OAI2

NAI means No Action Indicated. VAI means Voluntary Action Indicated. OAI means Official Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Raritan Pharmaceuticals, Inc. FDA Form 483, East Brunswick, New Jersey, October 20, 2016